AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

TRAZODONE HYDROCHLORIDE

11 registrations across 2 African markets— 7 active

Markets with TRAZODONE HYDROCHLORIDE

🇿🇦South Africa
9 registrations
5 active
🇿🇼Zimbabwe
2 registrations
2 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
TRAZOTOR 100
TABLET; ORAL
🇿🇼ZimbabweTORRENT PHARMACEUTICALSactiveNov 2030
TRAZOTOR 50
TABLET; ORAL
🇿🇼ZimbabweTORRENT PHARMACEUTICALSactiveNov 2030
DAZATRONE 100🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJul 2029
DAZATRONE 50🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJul 2029
ZADOPAX 50🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdunknownAug 2028
ZADOPAX 100🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdunknownAug 2028
MOLIPAXIN 100 mg CAPSULE🇿🇦South AfricaSanofi-Aventis South Africa (Pty) LtdsuspendedDec 2024
MOLIPAXIN 50 mg CAPSULE🇿🇦South AfricaSanofi-Aventis South Africa (Pty) LtdsuspendedDec 2024
BIO-TRAZODONE 100🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
ASPEN TRAZODONE 100 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
BIO-TRAZODONE 50🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900

TRAZODONE HYDROCHLORIDE in Africa — Regulatory Overview

TRAZODONE HYDROCHLORIDE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 7 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.